Transcatheter versus Surgical Aortic Valve Replacement in Bicuspid Aortic Valves
Recent approval of transcatheter aortic valve replacement (TAVR) in patients at lower risk profiles has resulted in a real-world expansion in patients with Bicuspid Aortic Valves (BAV), otherwise excluded from trials comparing TAVR to surgical aortic valve replacement (SAVR). Compare perioperative and longitudinal outcomes between BAV patients undergoing TAVR vs. SAVR.